15.12.2012 Views

Abstracts 4. Gemeinsamer Jahreskongress der ... - SWISS KNIFE

Abstracts 4. Gemeinsamer Jahreskongress der ... - SWISS KNIFE

Abstracts 4. Gemeinsamer Jahreskongress der ... - SWISS KNIFE

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

swissknife spezial 06 12.06.2006 13:39 Uhr Seite 13<br />

ring in the group of patients treated after a period of more than 24 hours from the onset of<br />

symptoms and only 2 deaths (14 %) in patients treated before 24 hours. Later complications,<br />

particularly esophageal stenosis, were observed in 4 patients (16 %) and managed with esophageal<br />

dilatation with success.<br />

Conclusion: Despite prompt treatment postoperative morbidity and mortality are still relevant.<br />

Eearly diagnosis and definitive surgical management are stil l the key for successful outcome<br />

in the management of spontaneous esophageal perforation. Primary suture with buttressing<br />

should be consi<strong>der</strong>ed as the procedure of choice. Conservative approach may be applied in<br />

very selected cases..<br />

3.04<br />

U. Stammberger 1 , W. Bauer 2 , R.A. Schmid 3<br />

1 DMLL, Klinik und Poliklinik für Thoraxchirurgie, 3010 Bern/CH, 2 Medizin, Pneumologie, 3012<br />

Bern/CH, 3 Klinik Und Poliklinik für Thoraxchirurgie, Inselspital, 3010 Bern/CH<br />

Improvement of diaphragm plication in patients with idiopathic diaphragm paralysis by a<br />

small diaphragmatic incision<br />

Objective: Diaphragm paralysis is caused by cardiac surgery, viral infections, different neurological<br />

disor<strong>der</strong>s or trauma, however, in more than half of the patients, the cause for nerval<br />

dysfunction remains unclear. Whereas unilateral left paralysis is well tolerated at least in<br />

adults, unilateral right or bilateral diaphragm paralysis leads to dyspnea and the inability to<br />

sleep in supine position, because the diaphragm is the only inspiratory muscle active during<br />

REM sleep. Plication of the diaphragm reduces paradoxic motion and increases the volume<br />

of the hemithorax. Either minimally invasive procedure by thoracoscopy, which are less effective<br />

due to suboptimal plication, or procedures via a large posterolateral thoracotomy are described<br />

in the literature.<br />

Methods: Two females with idiopathic diaphragm palsy un<strong>der</strong>went unilateral plication of the<br />

dia-phragm via a small muscle-sparing lateral thoracotomy combined with an incision in the<br />

diaphragm in or<strong>der</strong> to optimally retract intraabdominal organs, facilitating maximum plication<br />

via a small thoracic incision. After plication, the diaphragmatic incision is closed with<br />

monofilament sutures.<br />

Results: Postoperative course was uneventful in both patients. One patient with unilateral diaphragm<br />

paralysis who suffered hypoxemia, chronic lower lobe atelectasis and inability to<br />

walk stairs had significant improvement of lung function (VC pre 1.54, post 2.02 [L]; FEV1 pre<br />

1.07, post 1.48 [L/sec]), maximal static inspiratory and exspiratory pressures (PImax pre<br />

2.46, post 3.50; PEmax pre 5.84, post 8.74 [kPa]), oxygenation (PaO2 at ambient air pre 48,<br />

post 63 [mmHg], and reduction of shunt volume (Qs/Qt pre 18, post 14). The patient with<br />

bilateral paralysis who had been operated on the right side needed noninvasive ventilation<br />

during sleep (BiPAP). After the operation, she can sleep in supine position without ventilatory<br />

assistance. VC increased from 1.58 to 1.92 [L], whereas FEV1 improved only little (pre 1.17,<br />

post 1.33 [L/sec]). Maximal inspiratory (3.05 to 5.88) and exspiratory (pre 5.26; post 8.27<br />

[kPa]) pressures improved.<br />

Conclusion: Open diaphragmatic plication via a small lateral thoracotomy with diaphragmatic<br />

incision results in relief of symptoms as well as improvement of lung function and maximal<br />

static pressures.<br />

3.05<br />

N. Seidel 1 , B. Hoksch 2 , R.A. Schmid 3<br />

1 DMLL Inselspital, Clinic for Thoracic Surgery, 3005 Berne/CH, 2 University Hospital Bern/<br />

Inselspital, Clinic for Thoracic Surgery, 3 010 Berne/CH, 3Division of General Thoracic Surgery,<br />

University Hospital, 3010 Berne/CH<br />

Perioperativer Verlauf nach thorakoskopischer Talkpleurodese bei malignem Pleuraerguss<br />

Objective: Hintergrund: Im Zusammenhang mit Talkpleurodesen wird zum Teil über schwerwiegende<br />

Komplikationen bis hin zu Sepsis und Multiorganversagen berichtet. In einer retrospektiven<br />

Analyse wird das Outcome nach erfolgter thorakoskopischer Talkpleurodese bei<br />

malignem Pleuraerguss untersucht. Gleichzeitig soll eruiert werden, inwieweit eine intraoperative<br />

Pleurabiopsie zu einer erhöhten Komplikationsrate im postoperativen Verlauf führt.<br />

Methods: Material + Methodik: Im Zeitraum vom 1.1.2002 bis zum 31.12.2004 wurde bei 77<br />

Patienten mit rezidivierendem malignen Pleuraerguss und ausgeprägter Dyspnoe eine thorakoskopische<br />

Talkpleurodese durchgeführt. In <strong>der</strong> retrospektiven Aufarbeitung erfolgte eine<br />

Einteilung <strong>der</strong> Patienten in zwei Gruppen: Patienten mit (n = 50 [ 64,94%]) und Patienten<br />

ohne (n = 27 [35,06%]) Biopsieentnahme intraoperativ. Für beide Gruppen wurden sowohl<br />

<strong>der</strong> paraklinische Verlauf (CRP, Leukozyten) als auch Komplikationen, Morbidität und<br />

Mortalität erfasst.<br />

Results: Ergebnisse: Postoperativ war in beiden Gruppen bei allen Patienten ein deutlicher<br />

CRP- Anstieg zu verzeichnen, mit Punktum Maximum am 2. postoperativen Tag (Median =<br />

235 mg/L, Range 17 bis 456 mg/L). Zum Entlassungszeitpunkt lag <strong>der</strong> CRP- Wert im Median<br />

noch bei 113 mg/L (Range 16 bis 429 mg/L). Am 2. postoperativen Tag wurden im Median<br />

Leukozyten mit Werten von 9.40G/L (Range 0.80 bis 30.00 G/L) verzeichnet.<br />

Komplikationen traten bei 8 Patienten (10.4%) auf, wobei kein Unterschied zwischen den<br />

Patientengruppen mit o<strong>der</strong> ohne Biopsie bestand. Die Mortalitätsrate betrug 9,1%, wobei hier<br />

in nahezu allen Fällen (71,4 %) eine massive Tumorprogredienz ursächlich war. Nach <strong>der</strong> bisherigen<br />

Datenlage trat bei keinem Patienten ein Rezidiverguss auf.<br />

Conclusion: Schlussfolgerungen: Anhand <strong>der</strong> Datenlage kann gefolgert werden, dass die thorakoskopische<br />

Talkpleurodese eine sichere und vertretbare Methode ist, um die<br />

Lebensqualität von Patienten mit respiratorischen Einschränkungen in einer palliativen<br />

Situation zu verbessern. Dabei sollte die Indikation immer vom aktuellen Status/<br />

Allgemeinzustand des Patienten abhängig gemacht werden. Weiterhin konnte in <strong>der</strong> vorliegenden<br />

Arbeit festgestellt werden, dass Patienten mit einer Biopsieentnahme kein signifikant<br />

erhöhtes Risiko einer postoperativen Komplikation im Vergleich zu Patienten ohne<br />

Biopsieentnahme bei einer Talkpleurodese haben.<br />

3.06<br />

R. Fahrner 1 , B. Hoksch 1 , A. Gazdhar1, R.A. Schmid 2<br />

1 University Hospital Bern/Inselspital, Clinic for Thoracic Surgery, 3010 Berne/CH, 2 Division of<br />

General Thoracic Surgery, University Hospital, 3010 Berne/CH<br />

Procalcitonin as a parameter in the postoperative course of patients with talc pleurodesis<br />

Objective: Background: There are no informations about the course of Procalcitonin (PCT) in<br />

patients operated with a pleural effusion proven to be due to pleural malignancy by cytology<br />

and/or histology. The aim of this clinical pilot project was to assess the importance of PCT as<br />

a diagnostic paramater in patients un<strong>der</strong>going thoracoscopic pleurodesis with talc (graded<br />

talc). An improved rapid assay with a functional assay sensitivity of 0.06 ng/ml has become<br />

available (Fa. BRAHMS PCT-Kryptor-System) and was used for this question.<br />

Methods: Material/Methods: Since January 2005, 21 Patients admitted with pleural effusion<br />

caused by cancer were enrolled in this study. PCT, Interleukin (IL), and CrP plasma levels as<br />

well as clinical course were recorded preoperatively and postoperatively day 1-3 and on day<br />

of discharge.<br />

Results: Results: During the postoperative course the PCT levels elevated in all patients with a<br />

peak–level on day 2 (median 0.5198 [0,0783- 19.09] ng/ml). PCT levels declined from that<br />

day continuously. Most of the patients offered an only slight elevated PCT level by discharge<br />

(day 5) explainable by a low systemic inflammation/reaction (median 0.1965 [0.0662–<br />

0.6862] ng/ml). CrP also elevated to peak-level on day 2 (median 246 [64 528] ng/ml). On<br />

day of discharge (day 5) no patient showed a normal CrP value. 23.8 % of the patients had<br />

CrP levels of more than 50 mg/l, 42.9 % patients of more than 100 mg/l. The course of IL<br />

confirmed the systemic inflammation.<br />

Conclusion: Conclusion: PCT measurement showed a significant systemic<br />

inflammation/systemic reaction due to the pleurodesis with a decrease of this process beginning<br />

on day 2 postoperatively. The CrP showed a similiar pattern, but presented higher values<br />

on 5th day postoperatively. So PCT can help to differentiate systemic inflammation from<br />

infections postoperatively. The PCT seems to be an appropriate diagnostic parameter to monitor<br />

and optimize the course of these patients.<br />

3.07<br />

Q. Tan 1 , M. Welti 1 , S. Hillinger 2 , W. We<strong>der</strong> 2<br />

1 Thoracic Surgery, University Hospital Zurich, 8091 Zurich/CH, 2 Department of Thoracic<br />

Surgery, University of Zurich, Zurich/CH<br />

Design of „in-vivo bioreactor“ for the reepithelialization of tissue engineered trachea<br />

Objective: Our main goal is to invent a tissue-engineered neo-trachea to be implantable in<br />

patients with tracheal defects caused by cancer or stenosis. In this study we pioneer a concept<br />

of „in-vivo bioreactor”, defined as the design of a perfusion system inside scaffold, and<br />

test its advantages first in vitro.<br />

Methods: To establish a simple test model, we inserted a porous catheter inside a tubular<br />

DegraPol scaffold; connected the ends of the catheter to two pumps respectively. One pump<br />

continuously pumped medium into the scaffold while the other sucked the waste out. In reepithelialization<br />

exam, human tracheal epithelial cell line 16HBE14o was first seeded onto<br />

acellular porcine <strong>der</strong>mal (APD) scaffold. Supported by perfusion system in incubator for two<br />

weeks before scanning electronic microscopy (SEM). In a cell delivery trial, rat chondrocytes<br />

were added into perfusion medium, administered in a continuous way for one week to a<br />

DegraPol tube. MTT and histological assessment were chosen to prove the presence of living<br />

cells on the scaffold through this seeding approach. Regarding the angiogenesis test, we<br />

used the chorioallantoic membrane (CAM) angiogenesis model; the DegraPol tube of in-vivo<br />

bioreactor was put on top of the CAM surface and 40ng/ml VEGF inside the perfusion medium.<br />

After 5 days Bisbenzimide H 33342 was injected into CAM circulation system before<br />

sample harvest to prove normal functional vessel formation inside the scaffold.<br />

Results: SEM results prove that perfusion system inside the DegraPol scaffold can maintain<br />

the survival of epithelial cells on the APD outside surface. The design also serves as an efficient<br />

cell delivery approach. In the angiogenesis test CAM tissue grew into and biodegraded<br />

the DegraPol scaffold quickly and some typical effects of VEGF such as increased vascular<br />

permeability are found.<br />

Conclusion: Our study demonstrated that through the in-vivo bioreactor approach we can<br />

deliver, further maintain, the survival of seeded cells and accelerate the angiogenesis process.<br />

It combines the traditionally separated in-vitro and in-vivo parts in tissue engineering<br />

research and can also be used in the reconstruction of other tissue engineered organ, such<br />

as tissue engineered bone. In our view the design of the scaffold maybe the know-how to<br />

resolve the two key technical bottlenecks faced by tissue engineering research: revascularization<br />

and reepithelialization.<br />

3.08<br />

H. Winiker 1 , M.G. Schwöbel 1 , R. Schläpfer 2 , P. Stulz 2 , M. Jöhr 3<br />

1 Pediatric Surgery, Children's Hospital, 6000 Luzern/CH, 2 Herz-Thorax-Chirurgie, Kantonsspital,<br />

6000 Luzern/CH, 3 Anästhesiologisches Institut, Kantonsspital, 6000 Luzern/CH<br />

Ist die NUSS geknackt? Die minimal-invasive Trichterbrust – Operation nach NUSS: Wie lassen<br />

sich Komplikationen, Ernüchterung und schlechte Resultate vermeiden?<br />

Objective: Der Boom, welche die NUSS-Modifikation in Form einer minimal-invasiven Trichterbrust-Operation<br />

weltumspannend erreicht hat, ist auch in <strong>der</strong> Schweiz nicht aufzuhalten.<br />

Unsere Klinik gehört schweizweit zu den Ersten, die auf diesen Zug aufgesprungen ist, und<br />

„zahlenmässig“ zu den erfahrenen Instituten.<br />

Methods: Die Analyse von 70 minimal-invasiven Trichterbrust-Operationen nach <strong>der</strong> Methode<br />

von NUSS, ausgeführt in den Jahren 2000 – 2005, veranlassen uns auf die möglichen<br />

Komplikationen und <strong>der</strong>en Konsequenzen hinzuweisen.<br />

Results: Von insgesamt mehr als 100 evaluierten Patienten wurden 68 Kin<strong>der</strong>, Adoleszente<br />

o<strong>der</strong> Erwachsene (16 W und 52 M) mit 70 Eingriffen (2 x ReDo) nach <strong>der</strong> erwähnten<br />

Methode operiert. Die Alterspanne reicht von 8 bis 29 Jahre. Bei 15 Patienten (22%) traten 18<br />

unterschiedliche Komplikationen (13 minor, 5 major) auf, die als unbedeutend bis erheblich<br />

o<strong>der</strong> ernsthaft beurteilt werden müssen. Bleibende Störungen o<strong>der</strong> Schäden sind nicht zu verzeichnen.<br />

Conclusion: Es ist gerade bei dieser Operationstechnik, die sich einfach präsentiert und<br />

wegen <strong>der</strong> „minimalen Invasivität“ banal erscheint, beson<strong>der</strong>e Vorsicht geboten. Die „learning-curve“<br />

ist nicht unbedeutend und nicht zu unterschätzen. Das Komplikationenspektrum<br />

wird besprochen und Konsequenzen und Optionen für <strong>der</strong>en Vermeidung aufgezeigt.<br />

04<br />

<strong>4.</strong>01<br />

C. Senekowitsch 1 , A. Assadian 2 , G. Hagmüller 3<br />

1 Chirurgie, Wilhelminenspital <strong>der</strong> Stadt Wien, 1160 Wien/AT, 2 Chirurgie, Wilhelminenspital,<br />

1160 Wien/AT, 3 Chirurgie, Wilhelminenspital, Wien/AT<br />

swiss knife 2006; special edition 13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!